Fermín S. G.
- Country
- Spain
- Department
- Hematología
Research Overview
- Phase I/IIa Study of Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ectopically Expressing CXCR4 and IL-10 in Patients with Steroid- or Ruxolitinib-Refractory Acute GVHD
- Phase II Study on Reinduction and Cessation of Ponatinib in Chronic Myelogenous Leukemia Patients in Molecular Response
- Evaluation of Antiviral Prophylaxis with Cytolytic T Lymphocytes for Cytomegalovirus Infection in HLA-Identical Familial Hematopoietic Stem Cell Transplantation
Data & Insights
Has run more than one trial at 3 of 17 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating chronic myelogenous leukemia and B-cell aggressive lymphoma, with particular emphasis on innovative therapeutic approaches for treatment-resistant cases.
- CML Treatment Optimization
- Refractory Lymphoma Management
- Novel Cell Therapies
Their research extends to exploring treatment reinduction strategies and cellular therapeutic interventions.
Transplant Medicine
The investigator focuses on complications following hematopoietic stem cell transplantation, with specific attention to post-transplant infectious complications.
- Transplant-Related Infections
- Preventive Strategies
- Immune Reconstitution
Their work includes developing prophylactic approaches for transplant recipients.
Infectious Disease Management
The investigator specializes in managing cytomegalovirus infections in immunocompromised patients, particularly in the context of stem cell transplantation.
- Viral Infection Prevention
- Antiviral Strategies
- Cell-Based Therapies
Their research includes innovative approaches using specific CTLs for infection prevention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.